Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
Main Authors: | Omar Najjar, Aaron Varghese, Maryam Shahi, Russell Vang, Stephanie Gaillard, Thomas Smith, Amanda N. Fader |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920300217 |
Similar Items
-
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
by: Swaathi Jayaraman, et al.
Published: (2020-05-01) -
Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009) -
Increased Sclerostin Levels after Further Ablation of Remnant Estrogen by Aromatase Inhibitors
by: Wonjin Kim, et al.
Published: (2015-03-01) -
Biological Evaluation of New Compounds as Potential Aromatase Inhibitors for Estrogen-Dependent Breast Cancer
by: Maria Fernanda Dias Miranda Bernardo
Published: (2019) -
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.
by: Irene Moy, et al.
Published: (2013-01-01)